Evidence map›Paper›PMID 37575289›Full record

ArticleGlobal cardiology science & practice2023

Predictors of protein losing enteropathy after Fontan completion: An 8-year retrospective study at Sheikh Khalifa Medical City.

Antoine Fakhry AbdelMassih, Laszlo Kiraly, Hazem El Badaoui, Mohammad Khan, Balazs Hetharsi, Judit Noemi Till, Aleksandr Y Omelchenko, Alaa Ziad Salah, Farah Tarik Al Jburi, Laila Alkhouli and 16 more

Open access · diamondAbstract read
In one paragraph

Article in Global cardiology science & practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 2 institutions in 2 countries.

Antoine Fakhry AbdelMassihPediatric Cardiology unit, Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
Laszlo KiralyPediatric Cardiac Surgery at Department of Cardiac, Thoracic and Vascular Surgery, National University Hospital.
Hazem El BadaouiPediatric Cardiology Department, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.
Mohammad KhanPediatric Cardiology Division, Cardiac Sciences' department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Balazs HetharsiPediatric Cardiac Intensive Care Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Judit Noemi TillPediatric Cardiac Intensive Care Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Aleksandr Y OmelchenkoPediatric Cardiac surgery Division, Cardiac Sciences' department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Alaa Ziad SalahPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Farah Tarik Al JburiPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Laila AlkhouliPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Mina TaherPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Najah AlhosaniPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Omnia YoussefPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Sumaiya IqbalPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Zahraa AllamiPediatrics' Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Neerod Kumar JhaPediatric Cardiac surgery Division, Cardiac Sciences' department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Eman Mahmoud HamadPediatric Cardiac Intensive Care Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Yasmin OmarPediatric Cardiology unit, Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
Arshad KhanPediatric Echocardiography, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Zafar AzeezPediatric Cardiology Division, Cardiac Sciences' department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Michael AttiaCardiology department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Mariam MinaPediatrics' department, Danat Al Emarat Hospital for Women & Children, Abu Dhabi, UAE.
Alyaa Al AliPediatric Cardiac Intensive Care Department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Yara Khaled AfifiYas Clinic Group, Abu Dhabi, UAE.
Meryam El ShershabyPediatric Cardiology unit, Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
Afnan MuslehPediatric Cardiology Division, Cardiac Sciences' department, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Shaikh Khalifa Medical City · AECairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Fontan procedure is the final stage of a three-stage palliation process in patients born with a univentricular heart as part of hypoplastic left heart syndrome (HLHS) or other pathologies with a univentricular heart. As essential as this procedure has proven to be for such cases, the Fontan physiology diminishes cardiac output and expands systemic venous pressure, which then leads to venous congestion that can be complicated by protein-losing enteropathy (PLE). This retrospective study aimed to identify the predictors of such complications in all patients who underwent completion of the Fontan procedure at our center (Sheikh Khalifa Medical City/SKMC) in the past eight years.

methodsThis study examined the medical records of patients who underwent completion of Fontan repair at our center since the inauguration of the cardiac surgery program of SKMC in the United Arab Emirates (UAE) - 01 Jan 2012 to 31 Dec 2020. Exclusion criteria included the absence of any of the undermentioned data in patient files. Patients were divided into two groups: those who developed PLE and those who did not. For each group, the following data were collected: demographics data (current age and age at completion of Fontan), clinical and laboratory data (oxygen saturation, serum albumin), echocardiographic data (classification of original cardiac diagnosis, degree of atrio-ventricular valve regurgitation, ventricular functions), hemodynamic data (mean pressures of superior vena cava and pulmonary arteries before Fontan completion), operative data (type of initial palliation, type of Fontan, presence of fenestrations and its size) and the need for any cardiac intervention prior to Fontan completion, such as atrio-ventricular valve repair, peripheral pulmonary stenting and arch balloon dilatation.

resultsOf the 48 included patients,13 (25%) developed PLE. Multivariate regression analysis proved that the best predictors of PLE were superior vena cava mean pressure (

conclusionThis is a single-center study of the predictors of PLE after Fontan procedure and, as expected from similar studies, SVC pressure higher than 11 mmHg and moderate-to-severe atrio-ventricular valve regurgitation were predictors of Fontan failure. The higher prevalence of PLE in our cohort, as well as lower cut-offs of SVC pressure that can predict complications, may be related to the predominance of hypoplastic left heart in the operated patients, which has been the main referral center for cardiac surgeries in UAE in the last decade.

Identifiers

PMID37575289
PMCPMC10422871
OpenAlexW4385799343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.